DGX [NYSE]
Quest Diagnostics Incorporated
IndexS&P 500 P/E9.11 EPS (ttm)15.01 Insider Own0.70% Shs Outstand119.00M Perf Week-2.59%
Market Cap15.71B Forward P/E16.19 EPS next Y8.44 Insider Trans-34.77% Shs Float116.16M Perf Month-1.40%
Income1.87B PEG- EPS next Q2.20 Inst Own94.60% Short Float4.21% Perf Quarter-0.13%
Sales10.68B P/S1.47 EPS this Y48.20% Inst Trans0.90% Short Ratio4.71 Perf Half Y-20.23%
Book/sh53.59 P/B2.55 EPS next Y-8.52% ROA14.00% Target Price151.86 Perf Year2.81%
Cash/sh6.19 P/C22.07 EPS next 5Y-13.70% ROE29.90% 52W Range125.33 - 174.16 Perf YTD-21.00%
Dividend2.64 P/FCF12.14 EPS past 5Y28.00% ROI16.90% 52W High-21.52% Beta1.00
Dividend %1.93% Quick Ratio1.30 Sales past 5Y7.50% Gross Margin38.80% 52W Low9.06% ATR3.56
Employees40000 Current Ratio1.50 Sales Q/Q-4.00% Oper. Margin20.90% RSI (14)52.06 Volatility2.79% 2.39%
OptionableYes Debt/Eq0.63 EPS Q/Q-15.60% Profit Margin17.50% Rel Volume0.77 Prev Close132.98
ShortableYes LT Debt/Eq0.62 EarningsJul 21 BMO Payout16.10% Avg Volume1.04M Price136.68
Recom2.40 SMA201.92% SMA500.28% SMA200-4.59% Volume798,157 Change2.78%
Apr-04-22Downgrade Citigroup Buy → Neutral $175 → $140
Feb-23-22Downgrade UBS Buy → Neutral $160 → $139
Feb-02-22Downgrade Jefferies Buy → Hold $135
Jan-28-22Downgrade Deutsche Bank Buy → Hold $190 → $129
May-04-21Upgrade UBS Neutral → Buy $135 → $158
Mar-12-21Downgrade Robert W. Baird Outperform → Neutral $137
Oct-21-20Upgrade Argus Hold → Buy
Jul-29-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $144
Jul-14-20Upgrade BofA Securities Neutral → Buy $142
Jun-09-20Upgrade Wells Fargo Underweight → Equal Weight $90 → $120
Jun-02-20Upgrade Deutsche Bank Hold → Buy $140
Apr-28-20Upgrade Morgan Stanley Equal-Weight → Overweight $139
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $113 → $130
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $95
Jan-08-20Initiated Wells Fargo Underweight $100
Jan-07-20Downgrade Barclays Overweight → Equal Weight $106
Dec-19-19Upgrade BofA/Merrill Underperform → Neutral $94 → $110
Jul-15-19Downgrade Goldman Neutral → Sell $90 → $85
Apr-02-19Upgrade Jefferies Hold → Buy $93 → $107
Jul-01-22 10:33AM  
Jun-30-22 01:53PM  
Jun-27-22 02:30PM  
06:02AM  
Jun-24-22 04:09PM  
Jun-23-22 06:06PM  
09:40AM  
Jun-22-22 10:35AM  
08:50AM  
Jun-21-22 02:25PM  
09:00AM  
Jun-20-22 09:00AM  
Jun-17-22 03:05PM  
Jun-15-22 10:38AM  
Jun-14-22 10:30AM  
08:37AM  
Jun-13-22 07:30AM  
Jun-09-22 04:21PM  
12:00PM  
Jun-08-22 09:30AM  
Jun-07-22 11:11AM  
Jun-06-22 09:18AM  
07:30AM  
Jun-03-22 11:02AM  
Jun-02-22 08:55AM  
May-30-22 11:44AM  
09:30AM  
May-27-22 01:31PM  
May-26-22 03:41PM  
10:53AM  
May-25-22 12:37PM  
12:30PM  
May-20-22 10:01PM  
May-19-22 12:36PM  
May-17-22 04:52PM  
May-13-22 10:04AM  
May-11-22 01:40PM  
May-09-22 07:30AM  
May-06-22 07:33AM  
May-03-22 09:30AM  
May-02-22 11:31AM  
07:31AM  
Apr-28-22 09:06AM  
Apr-27-22 03:31PM  
Apr-21-22 11:16AM  
10:55AM  
10:16AM  
08:15AM  
07:56AM  
06:59AM  
06:45AM  
Apr-20-22 04:10PM  
12:01PM  
Apr-19-22 08:42AM  
Apr-18-22 09:03AM  
Apr-14-22 03:00PM  
Apr-12-22 10:01AM  
Apr-11-22 02:26PM  
Apr-07-22 01:01PM  
Apr-06-22 09:35AM  
Apr-04-22 06:11PM  
12:18PM  
08:55AM  
08:31AM  
Mar-31-22 12:01PM  
Mar-30-22 09:09AM  
08:03AM  
Mar-29-22 04:46PM  
Mar-27-22 02:01PM  
Mar-24-22 10:23AM  
10:00AM  
08:51AM  
Mar-23-22 05:18PM  
10:46AM  
Mar-21-22 12:14PM  
08:45AM  
Mar-15-22 10:03AM  
07:00AM  
Mar-14-22 10:37AM  
Mar-11-22 09:30AM  
Mar-10-22 12:05PM  
Mar-09-22 09:59AM  
Mar-08-22 11:36AM  
Mar-07-22 02:21PM  
Mar-03-22 10:02AM  
09:04AM  
Mar-02-22 11:02AM  
Mar-01-22 11:21AM  
Feb-25-22 02:50PM  
Feb-24-22 03:20PM  
Feb-23-22 06:20PM  
02:49AM  
Feb-22-22 12:55PM  
Feb-15-22 01:00PM  
Feb-11-22 06:30PM  
Feb-10-22 06:32AM  
Feb-08-22 04:21PM  
Feb-06-22 04:33PM  
Feb-03-22 02:55PM  
01:38PM  
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMay 24Option Exercise94.20282,40826,601,579491,115May 25 04:31 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMay 24Sale140.12282,40839,571,322334,833May 25 04:31 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMay 23Option Exercise94.2677,4667,302,052377,401May 25 04:31 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMay 23Sale140.1777,46610,858,220334,833May 25 04:31 PM
PREVOZNIK MICHAEL ESVP & General CounselMay 17Option Exercise66.5150,6043,365,67289,828May 19 04:40 PM
PREVOZNIK MICHAEL ESVP & General CounselMay 17Sale139.9750,6047,082,99139,224May 19 04:40 PM
PREVOZNIK MICHAEL ESVP & General CounselMar 08Sale135.216,228842,08839,224Mar 09 04:50 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Mar 08Sale135.217,032950,79767,733Mar 09 04:40 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 28Sale130.0066185,93039,224Mar 02 04:44 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 24Sale126.262,750347,21564,405Feb 28 07:50 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 24Sale126.261,669210,72837,144Feb 28 07:35 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Nov 29Option Exercise95.8037,5653,598,539106,294Dec 01 04:34 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Nov 29Sale156.8137,5655,890,57568,729Dec 01 04:34 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 29Option Exercise95.809,493909,382289,727Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 29Sale140.879,4931,337,251284,427Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 28Option Exercise95.80139,75113,387,447424,178Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 28Sale140.14139,75119,584,845284,427Jul 30 04:16 PM
WILENSKY GAIL RDirectorJul 27Option Exercise59.3912,222725,92623,956Jul 28 04:18 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 27Option Exercise95.8032,7883,140,926317,215Jul 28 04:21 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 27Sale140.0132,7884,590,550284,427Jul 28 04:21 PM
WILENSKY GAIL RDirectorJul 27Sale139.3012,2221,702,47017,845Jul 28 04:18 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 26Option Exercise95.805,813556,856290,240Jul 28 04:21 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 26Sale140.035,813813,994284,427Jul 28 04:21 PM